First-in-human clinical trial testing CRISPR/Cas9 gene-editing in 12 highly metastatic, end-stage GI cancer patients saw several of their cancer growth halt & not return over 2 year period.

submitted 2 weeks ago by

I have seen enough loved ones affected by GI cancer, the only bad thing about this news is that it didn't come ten years ago!